Saturday, July 11, 2026

The Week in Review

Market Regime

RISK-ON the regime engine's latest close-of-day read, carried into the weekend (markets closed).

The regime engine's close-of-day read is RISK-ON, unchanged from the prior week's call. The tape didn't argue with it. VIX sat at 16.9 calm. Breadth stayed healthy, with 60.9% of names (596/978) holding above their 200-EMA. SPY closed the week at 751.55, running +8.6% above its own 200-EMA.

Rates drifted up without disturbing anything underneath. The 10Y finished at 4.54% (+5bps WoW), the 2Y at 4.16% (+2bps), and the 10Y-2Y spread held at 0.35% (flat WoW) no fresh curve signal either way. The real 10Y rate ticked to 2.30% (+4bps) while breakevens barely moved at 2.24% (+1bps), so the move was real-yield, not inflation scare. The cleaner tell was credit: high-yield spreads tightened to 2.70% (-4bps WoW), which is not the direction spreads travel when risk appetite is rolling over. Labor stayed firm into the read initial jobless claims printed 215K (-2K WoW), unemployment 4.2%, payrolls 159.0M, Fed Funds 3.63%. Add it up and the backdrop that let the momentum book breathe all week is still intact.

Themes in Motion

Nine of the ten tracked themes are still ACCELERATING, and the leadership is where you'd want it in a RISK-ON tape compute and its supply chain, plus a broad biotech complex:

• AI chips & memory (7), AI datacenter infrastructure (5), GPU cloud & neoclouds (5) the core compute trade, still pulling.
• Networking & optical (6) the pick-and-shovel layer under the datacenter build, accelerating alongside it.
• Oncology & immunology (16) and Rare disease & gene therapy (11) the two deepest benches on the board, both strengthening.
• Space economy (9), Cybersecurity (4), Crypto exchanges & financials (4) smaller cohorts, same acceleration signature.

The lone laggard by state is Nuclear & uranium (7) [MATURING] the one theme where the playbook wants a pullback to MA support before adding, not a chase of the extension.

Under the Lens

265 dossiers deep-refreshed this week. The highest-conviction setup coming out of the pass is AVGO (Broadcom) at HIGH sitting at the intersection of AI chips & memory and the optical/networking build, exactly where two accelerating themes overlap. Around it, the refresh concentrated on the compute supply chain and the biotech bench:

• ALAB (Astera Labs) connectivity silicon levered directly to the datacenter buildout; accelerating theme, clean narrative.
• AMD the second front in AI chips & memory; the read is confirmation of theme strength, not a lone breakout.
• AMAT (Applied Materials) and AMKR (Amkor) the equipment and packaging layer; when these refresh alongside the logic names, the whole chain is moving together.
• AAOI (Applied Optoelectronics) a networking & optical name riding the same optical-interconnect demand as AVGO's optical franchise.
• ABVX (Abivax), AGIO (Agios), ABCL (AbCellera) the oncology/immunology and rare-disease cohort; deep benches, catalyst-driven, watched into their own event calendars rather than the tape.

The Week Ahead

Next week is a catalyst wall, and most of it lands T-3 or sooner binary-risk territory the playbook treats as watch-not-chase:

• Mon 7/12: BBWI (T-1d).
• Tue 7/13: HOOD (T-2d) the marquee print, a crypto exchanges & financials name in an accelerating theme; PENN, PGNY, PLSE alongside.
• Wed 7/14: AMZN (T-3d) the one that matters for the compute complex; plus ANAB, and the Argentine financials cluster BBAR / GGAL.
• Thu 7/15: LEGN (oncology), BTDR (crypto), JBHT (transport read-through), and the cannabis pair ACB / CGC.

The stance into all of it is the same: no new binary risk inside three trading days of a print. The names to actually engage are the ones the refresh surfaced whose thesis isn't earnings-gated the compute chain around AVGO where an accelerating, cluster-confirmed setup is the signal, and a clean entry doesn't require sitting through a coin-flip. Watching AMZN and HOOD for what their reactions say about datacenter demand and crypto-financial appetite, then acting on the follow-through, not the gap.

--